Resources
Filter by Topic
- Blogs
By David Kreutter, PhD
- Blogs
Q&A with Vijay Raghavan, Associate Vice President, Market Analytics and Business Insights, AbbVie
- Press Releases
Report examines the drivers, barriers, and benefits of using real-world data (RWD) and advanced analytics
- Publication
Authors: Nina Shah, Matthew Sussman, Concetta Crivera, Satish Valluri, Jennifer Benner & Sundar Jagannath Published: Clinical Drug Investigation Click here to view the article.
- Press Releases
Panalgo’s IHD software to be used by the EMA to rapidly answer questions around drug safety and efficacy and better understand real-world medication use.
- News & Events
PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, has named IHD’s Data Science module as...
- Blogs
Q&A with Dr. Mark Friedman
The Importance of Accounting for Time-Related Bias in Single-Arm Trials with Historical Controls (Part 2)
In our previous blog post, we sat down with Dr. Samy Suissa, the co-founder and principal investigator of the Canadian Network for Observational Drug Effect Studies,
The Importance of Accounting for Time-Related Bias in Single-Arm Trials with Historical Controls (Part 1)
Randomized control trials (RCTs) are typically heralded as the gold standard in clinical trial design. However, regulatory agencies are increasingly recognizing the role of single-arm
Using Machine Learning in the Evolving Landscape of Real-World Data
In this article with HIT Consultant, Zeynep Icten, PhD, (Director of Data Science Solutions at Panalgo) discusses the predictive power of machine learning for healthcare
IHD Analytics
Put reliable, rapid analytics in the hands of more people across your organization